Related Experiment Video
Updated: Aug 15, 2026
Real-time Bioluminescence Imaging of Notch Signaling Dynamics during Murine Neurogenesis
Published on: December 12, 2019
Turning on a dimer: new insights into MLL chimeras
1Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract:
In this issue of Cancer Cell, demonstrate a novel mechanism for the oncogenic activity of MLL chimeric proteins. By providing coiled-coil or other dimerization domains, the cytoplasmic partners of MLL fusion proteins donate a platform for MLL homodimerization, allowing recruitment of accessory factors needed to activate the critical downstream targets, including selected subsets of the major HOX genes.
Insights
This study reveals how MLL chimeric proteins drive cancer. Cytoplasmic partners enable MLL homodimerization, activating key cancer-promoting genes like HOX genes.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Mixed Lineage Leukemia (MLL) gene rearrangements are common in certain leukemias.
- MLL fusion proteins are known oncogenic drivers.
- The precise mechanism of MLL oncogenic activity remains incompletely understood.
Purpose of the Study:
- To elucidate a novel mechanism for the oncogenic activity of MLL chimeric proteins.
- To identify the role of cytoplasmic partners in MLL fusion protein function.
- To understand how MLL fusion proteins activate critical downstream targets.
Main Methods:
- Investigated the role of dimerization domains in MLL fusion proteins.
- Analyzed the formation of MLL homodimers.
- Examined the recruitment of accessory factors.
- Assessed the activation of downstream targets, including HOX genes.
Main Results:
- Cytoplasmic partners provide dimerization domains for MLL fusion proteins.
- These domains facilitate MLL homodimerization.
- MLL homodimerization is essential for recruiting accessory factors.
- This process leads to the activation of specific HOX genes, contributing to oncogenesis.
Conclusions:
- A novel mechanism for MLL oncogenic activity involving homodimerization has been demonstrated.
- Cytoplasmic partners play a crucial role in MLL fusion protein-mediated oncogenesis.
- Targeting MLL homodimerization or downstream HOX gene activation may offer therapeutic strategies for MLL-driven leukemias.
